Skip to Main Content
ManagedCareEye.com
This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources

ManagedCareEye.com Presents: Managed Care Consensus Recommendations to Facilitate Equitable Access and Optimal Outcomes for Retinal Diseases

August 1, 2024

FEATURING: Mark Barakat, MD, Justin Weiss, PharmD, MBA

← Diabetic Retinopathy/Diabetic Macular Edema (DR/DME) – Payer Implications Fact Sheet   Applying Regional Health Plan Best Practices in the Treatment of AMD and DR/DME →
  • About Impact Education, LLC
  • Contact Us (IMPACT)
  • Mailing List (IMPACT)
  • Privacy Policy

Jointly provided by

Medical Education Resources Impact Education, LLC

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

NEW Publication

Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases

Read Now